Covaxin

Until Covaxin gets an emergency use authorisation from WHO it cannot get widespread acceptability as a safe and effective vaccine around the world.

The WHO said on Monday it was “aware that many people are waiting for WHO’s recommendation for Covaxin to be included in the Covid-19 emergency use listing..

The WHO on Monday said it cannot cut corners and needs to thoroughly evaluate a product before recommending it for EUL to ensure it is safe and effective. “We..

The final approval for Bharat Biotech's Covaxin for children aged 2-18 years is under experts opinion and evaluation, stated Government sources on Thursday...

One million shots of Covaxin produced by Bharat Biotech were shipped to Iran last week, the Indian embassy in Tehran said. Vaccines have also been sent to Nepal,..

The final approval of EUA from the drug regulator and inclusion of the vaccine in the national Covid immunisation programme for the paediatric population will..

Covaxin approved for kids between 2-18